Gregory C. Flaker

1.7k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Gregory C. Flaker is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Gregory C. Flaker has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Gregory C. Flaker's work include Atrial Fibrillation Management and Outcomes (8 papers), Cardiac Arrhythmias and Treatments (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Gregory C. Flaker is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Cardiac Arrhythmias and Treatments (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Gregory C. Flaker collaborates with scholars based in United States, China and Canada. Gregory C. Flaker's co-authors include Stuart J. Connolly, Salim Yusuf, Janice Pogue, Patrick Commerford, Maria Grazia Franzosi, Jeff S. Healey, John W. Eikelboom, Albert L. Waldo, John Dimarco and H.Leon Greene and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Gregory C. Flaker

20 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

2008 640 citations Stuart J. Connolly, Janice Pogue et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory C. Flaker United States	12	1.0k	428	128	124	83	20	1.2k
María Asunción Esteve‐Pastor Spain	19	798 0.8×	307 0.7×	62 0.5×	166 1.3×	77 0.9×	85	1.0k
Frits R. Rosendaal Netherlands	6	677 0.7×	342 0.8×	129 1.0×	193 1.6×	39 0.5×	13	871
Michael Hanna United States	20	2.0k 1.9×	773 1.8×	119 0.9×	293 2.4×	61 0.7×	44	2.2k
Mette Hurlen Norway	11	900 0.9×	400 0.9×	211 1.6×	102 0.8×	24 0.3×	18	1.1k
A M H P van den Besselaar Netherlands	18	431 0.4×	271 0.6×	158 1.2×	80 0.6×	56 0.7×	53	865
Bcps United States	5	724 0.7×	508 1.2×	136 1.1×	172 1.4×	19 0.2×	48	985
Yasser Khder France	13	1.6k 1.5×	573 1.3×	224 1.8×	226 1.8×	25 0.3×	24	1.8k
Gregory Y H Lip United Kingdom	13	863 0.8×	287 0.7×	89 0.7×	141 1.1×	52 0.6×	41	963
Linda Harrison Canada	7	900 0.9×	954 2.2×	402 3.1×	65 0.5×	25 0.3×	8	1.2k
Lars Hvilsted Rasmussen Denmark	5	617 0.6×	303 0.7×	75 0.6×	70 0.6×	22 0.3×	6	679

Countries citing papers authored by Gregory C. Flaker

Since Specialization

Citations

This map shows the geographic impact of Gregory C. Flaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory C. Flaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory C. Flaker more than expected).

Fields of papers citing papers by Gregory C. Flaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory C. Flaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory C. Flaker. The network helps show where Gregory C. Flaker may publish in the future.

Co-authorship network of co-authors of Gregory C. Flaker

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory C. Flaker. A scholar is included among the top collaborators of Gregory C. Flaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory C. Flaker. Gregory C. Flaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Yuqi, Qiang Zhu, Hong Hao, Gregory C. Flaker, & Zhenguo Liu. (2023). N-Acetylcysteine and Atherosclerosis: Promises and Challenges. Antioxidants. 12(12). 2073–2073. 14 indexed citations

Xiao, Yichao, Xuanyou Liu, Yuqi Cui, et al.. (2022). N-acetylcysteine attenuates atherosclerosis progression in aging LDL receptor deficient mice with preserved M2 macrophages and increased CD146. Atherosclerosis. 357. 41–50. 11 indexed citations

Zhu, Qiang, Xuanyou Liu, Zehao Liu, et al.. (2022). N-Acetylcysteine Enhances the Recovery of Ischemic Limb in Type-2 Diabetic Mice. Antioxidants. 11(6). 1097–1097. 8 indexed citations

Li, Huan, Xiaoming Liu, Rong Li, et al.. (2020). Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome‐Mediated Mechanism. Journal of the American Heart Association. 9(6). e014120–e014120. 52 indexed citations

Koerber, Scott, et al.. (2018). Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study. Journal of Interventional Cardiac Electrophysiology. 54(2). 171–176. 6 indexed citations

Al‐Khatib, Sana M., Laine Thomas, Lars Wallentin, et al.. (2013). Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. European Heart Journal. 34(31). 2464–2471. 136 indexed citations

Flaker, Gregory C., et al.. (2011). A 46-year-old man with fever, ST-segment elevation. Cleveland Clinic Journal of Medicine. 78(5). 286–288. 2 indexed citations

Parekh, Amit, Stuart J. Connolly, Lars Wallentin, et al.. (2010). DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION - AN ANALYSIS OF PATIENTS UNDERGOING CARDIOVERSION. Journal of the American College of Cardiology. 55(10). A4.E40–A4.E40. 38 indexed citations

Connolly, Stuart J., Janice Pogue, John W. Eikelboom, et al.. (2008). Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range. Circulation. 118(20). 2029–2037. 640 indexed citations breakdown →

10.

Steinberg, Benjamin A., Gemma Eminowicz, Peter M. DiBattiste, et al.. (2005). Are Statins Being Underdosed in Clinical Practice?. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 4(4). 169–173. 7 indexed citations

11.

Dimarco, John, Gregory C. Flaker, Albert L. Waldo, et al.. (2005). Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. American Heart Journal. 149(4). 650–656. 163 indexed citations

12.

Dimarco, John, Gregory C. Flaker, & Albert L. Waldo. (2005). Factors Affecting Bleeding Risk During Anticoagulant Therapy in Patients With Atrial Fibrillation: Observations From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. ACC Current Journal Review. 14(8). 54–54. 4 indexed citations

13.

Govindarajan, Gurushankar, et al.. (2004). The Role of Nitric Oxide and Vasopressin in Refractory Right Heart Failure. Journal of Cardiovascular Pharmacology and Therapeutics. 9(1). 9–11. 8 indexed citations

14.

Flaker, Gregory C., et al.. (2002). How Do HMG-CoA Reductase Inhibitors Prevent Stroke?. American Journal of Cardiovascular Drugs. 2(1). 7–14. 12 indexed citations

15.

Jayam, Vinod, et al.. (2002). Atrial Fibrillation after Coronary Bypass: Etiology and Pharmacologic Prevention. Cardiovascular Surgery. 10(4). 351–358. 2 indexed citations

16.

Drury, John H., et al.. (2000). Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: A mechanism for reducing clinical events?. American Heart Journal. 139(4). 734–738. 30 indexed citations

17.

Flaker, Gregory C., et al.. (1994). Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.. PubMed. 154(13). 1492–6. 11 indexed citations

18.

Lamas, Gervasio A., et al.. (1992). Does Dual Chamber or Atrial Pacing Prevent Atrial Fibrillation? The Need for a Randomized Controlled Trial. Pacing and Clinical Electrophysiology. 15(8). 1109–1113. 32 indexed citations

19.

Giudici, Michael, Gregory C. Flaker, & Jack J. Curtis. (1991). Intraoperative Myocardial Infarction during Open‐Heart Ablation of an Atrioventricular Accessory Pathway. Pacing and Clinical Electrophysiology. 14(3). 399–403. 1 indexed citations

20.

Curtis, Jennifer, Mike Boland, David P. Bliss, et al.. (1988). Intra-aortic balloon cardiac assist: complication rates for the surgical and percutaneous insertion techniques.. PubMed. 54(3). 142–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact